104 related articles for article (PubMed ID: 11241793)
21. bcl 10 gene mutation in hepatocellular carcinoma.
Cheng J; Leng X; Cai S; Cao Z; Cao G; Peng J; Wang S; Du R
Chin Med J (Engl); 2001 Jul; 114(7):747-51. PubMed ID: 11780342
[TBL] [Abstract][Full Text] [Related]
22. Fluorescence in situ hybridization analysis of aneuploidization patterns in monoclonal gammopathy of undetermined significance versus multiple myeloma and plasma cell leukemia.
Rasillo A; Tabernero MD; Sánchez ML; Pérez de Andrés M; Martín Ayuso M; Hernández J; Moro MJ; Fernández-Calvo J; Sayagués JM; Bortoluci A; San Miguel JF; Orfao A
Cancer; 2003 Feb; 97(3):601-9. PubMed ID: 12548602
[TBL] [Abstract][Full Text] [Related]
23. Gene expression profiling of plasma cell dyscrasias reveals molecular patterns associated with distinct IGH translocations in multiple myeloma.
Mattioli M; Agnelli L; Fabris S; Baldini L; Morabito F; Bicciato S; Verdelli D; Intini D; Nobili L; Cro L; Pruneri G; Callea V; Stelitano C; Maiolo AT; Lombardi L; Neri A
Oncogene; 2005 Apr; 24(15):2461-73. PubMed ID: 15735737
[TBL] [Abstract][Full Text] [Related]
24. High frequency of frameshift mutation on p53 gene in Taiwanese with non small cell lung cancer.
Chang MY; Chong IW; Chen FM; Wang JY; Cheng TL; Cheng YJ; Sheu CC; Hung SY; Yang MC; Lin SR
Cancer Lett; 2005 May; 222(2):195-204. PubMed ID: 15863268
[TBL] [Abstract][Full Text] [Related]
25. [Mutation analysis of the tumor suppressor gene PTEN/MMAC1/TEP1 in human hepatocellular carcinoma].
Zhang LN; Zha XL; Yu Q; He JY
Shi Yan Sheng Wu Xue Bao; 2000 Sep; 33(3):223-7. PubMed ID: 12549040
[TBL] [Abstract][Full Text] [Related]
26. Epigenetic dysregulation of secreted Frizzled-related proteins in multiple myeloma.
Jost E; Gezer D; Wilop S; Suzuki H; Herman JG; Osieka R; Galm O
Cancer Lett; 2009 Aug; 281(1):24-31. PubMed ID: 19299079
[TBL] [Abstract][Full Text] [Related]
27. Kinetics of plasma-cell chimerism after allogeneic stem cell transplantation by highly sensitive real-time PCR based on sequence polymorphism and its value to quantify minimal residual disease in patients with multiple myeloma.
Kröger N; Zagrivnaja M; Schwartz S; Badbaran A; Zabelina T; Lioznov M; Ayuk F; Zander A; Fehse B
Exp Hematol; 2006 May; 34(5):688-94. PubMed ID: 16647575
[TBL] [Abstract][Full Text] [Related]
28. [The status of p53 gene in the primary retinoblastoma].
Huang Q
Zhonghua Yan Ke Za Zhi; 1999 Jul; 35(4):248-51. PubMed ID: 11835813
[TBL] [Abstract][Full Text] [Related]
29. Screening for mutations of Bcl10 in leukaemia.
Grimwade D; Du MQ; Langabeer S; Rogers J; Solomon E
Br J Haematol; 2000 Jun; 109(3):611-5. PubMed ID: 10886211
[TBL] [Abstract][Full Text] [Related]
30. Molecular analysis of unknown beta-globin gene mutations using polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP) technique and its application in Thai families with beta-thalassemias and beta-globin variants.
Chinchang W; Viprakasit V; Pung-Amritt P; Tanphaichitr VS; Yenchitsomanus PT
Clin Biochem; 2005 Nov; 38(11):987-96. PubMed ID: 16139831
[TBL] [Abstract][Full Text] [Related]
31. Identification of cyclin D1 mRNA overexpression in B-cell neoplasias by real-time reverse transcription-PCR of microdissected paraffin sections.
Specht K; Kremer M; Müller U; Dirnhofer S; Rosemann M; Höfler H; Quintanilla-Martinez L; Fend F
Clin Cancer Res; 2002 Sep; 8(9):2902-11. PubMed ID: 12231535
[TBL] [Abstract][Full Text] [Related]
32. A comprehensive survey of mutations in the OPA1 gene in patients with autosomal dominant optic atrophy.
Thiselton DL; Alexander C; Taanman JW; Brooks S; Rosenberg T; Eiberg H; Andreasson S; Van Regemorter N; Munier FL; Moore AT; Bhattacharya SS; Votruba M
Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):1715-24. PubMed ID: 12036970
[TBL] [Abstract][Full Text] [Related]
33. Efficient mutation detection in MEN1 gene using a combination of single-strand conformation polymorphism (MDGA) and heteroduplex analysis.
Crépin M; Escande F; Pigny P; Buisine MP; Calender A; Porchet N; Odou MF;
Electrophoresis; 2003 Jan; 24(1-2):26-33. PubMed ID: 12652570
[TBL] [Abstract][Full Text] [Related]
34. Infrequent somatic Fas mutations but no evidence of Bcl10 mutations or t(11;18) in primary cutaneous MALT-type lymphoma.
Grønbaek K; Ralfkiaer E; Kalla J; Skovgaard GL; Guldberg P
J Pathol; 2003 Sep; 201(1):134-40. PubMed ID: 12950026
[TBL] [Abstract][Full Text] [Related]
35. Status of the DPC4 tumor suppressor gene in sporadic colon adenocarcinoma of Croatian patients: identification of a novel somatic mutation.
Popović Hadzija M; Radosevic S; Kovacević D; Lukac J; Hadzija M; Spaventi R; Pavelić K; Kapitanović S
Mutat Res; 2004 Apr; 548(1-2):61-73. PubMed ID: 15063137
[TBL] [Abstract][Full Text] [Related]
36. Mutational activation of N- and K-ras oncogenes in plasma cell dyscrasias.
Corradini P; Ladetto M; Voena C; Palumbo A; Inghirami G; Knowles DM; Boccadoro M; Pileri A
Blood; 1993 May; 81(10):2708-13. PubMed ID: 8490179
[TBL] [Abstract][Full Text] [Related]
37. A novel splice-site variant of the base excision repair gene MYH is associated with production of an aberrant mRNA transcript encoding a truncated MYH protein not localized in the nucleus.
Tao H; Shinmura K; Hanaoka T; Natsukawa S; Shaura K; Koizumi Y; Kasuga Y; Ozawa T; Tsujinaka T; Li Z; Yamaguchi S; Yokota J; Sugimura H; Tsugane S
Carcinogenesis; 2004 Oct; 25(10):1859-66. PubMed ID: 15180946
[TBL] [Abstract][Full Text] [Related]
38. MALT lymphoma with t(14;18)(q32;q21)/IGH-MALT1 is characterized by strong cytoplasmic MALT1 and BCL10 expression.
Ye H; Gong L; Liu H; Hamoudi RA; Shirali S; Ho L; Chott A; Streubel B; Siebert R; Gesk S; Martin-Subero JI; Radford JA; Banerjee S; Nicholson AG; Ranaldi R; Remstein ED; Gao Z; Zheng J; Isaacson PG; Dogan A; Du MQ
J Pathol; 2005 Feb; 205(3):293-301. PubMed ID: 15682443
[TBL] [Abstract][Full Text] [Related]
39. Detection of a novel point mutation in the p53 gene in grade II astrocytomas by PCR-SSCP analysis with additional Klenow treatment.
Chawengchao B; Petmitr S; Ponglikitmongkol M; Chanyavanich V; Sangruji T; Theerapuncharoen V; Hayashi K; Thangnipon W
Anticancer Res; 2001; 21(4A):2739-43. PubMed ID: 11724349
[TBL] [Abstract][Full Text] [Related]
40. Reduced folate carrier mutations are not the mechanism underlying methotrexate resistance in childhood acute lymphoblastic leukemia.
Kaufman Y; Drori S; Cole PD; Kamen BA; Sirota J; Ifergan I; Arush MW; Elhasid R; Sahar D; Kaspers GJ; Jansen G; Matherly LH; Rechavi G; Toren A; Assaraf YG
Cancer; 2004 Feb; 100(4):773-82. PubMed ID: 14770434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
